ARO Medical赞助的临床试验
总计56767个结果
-
Ark Biosciences Inc.完全的
-
Arog Pharmaceuticals, Inc.撤销复发/难治性 FLT3 突变 AML
-
Taro Pharmaceuticals USA完全的
-
Taro Pharmaceuticals USA完全的
-
AGO Study Group完全的
-
AIO-Studien-gGmbH不再可用接受卡培他滨治疗的患有胃肠道肿瘤或乳腺癌的手足综合征患者的治疗德国
-
Ark Therapeutics Ltd终止
-
AstraZenecaMedical Writer: Dr. Rodrigo Athanazio; CRO: CTI-Eurotrials完全的
-
Istituto Auxologico ItalianoYGHEA, CRO Division of Ecol Studio spa; Apnimed Inc.; STM Pharma PRO srl完全的
-
GMG Grand MedicalGama CRO Tıbbi İlaç Araştırma Org.Tic.Ltd.Şti尚未招聘
-
Respinor ASCentaur Clinical CRO; Link Medical Research AS完全的
-
Wim JanssensPro-Active Medical Pty Ltd完全的
-
Nucletron Operations BVFactory CRO for Medical Devices B.V.完全的